News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Partner Pronova BioPharma Settles Drug Case with Apotex Inc.; Apotex to Sell Generic Lovaza in U.S. from Q1 2015


3/30/2011 7:20:50 AM

LONDON, March 30 (Reuters) - Norway's Pronova BioPharma (PRON.OL), which supplies the omega-3 heart medicine Lovaza to GlaxoSmithKline (GSK.L), settled a U.S. patent row with generics company Apotex, sending Pronova shares sharply higher.

Read at Reuters
Read at Bloomberg
Read at Nasdaq
Read at RTT News
Read at Forbes
Read at Washington Post


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES